Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia.

Patrick DL, Burns T, Morosini P, Rothman M, Gagnon DD, Wild D, Adriaenssen I.

Curr Med Res Opin. 2009 Feb;25(2):325-38. doi: 10.1185/03007990802611919 .

PMID:
19192977
2.

Paliperidone extended-release for the treatment of schizophrenia.

Marino J, Caballero J.

Pharmacotherapy. 2008 Oct;28(10):1283-98. doi: 10.1592/phco.28.10.1283. Review.

PMID:
18823223
3.

Paliperidone: a new extended-release oral atypical antipsychotic.

Dlugosz H, Nasrallah HA.

Expert Opin Pharmacother. 2007 Oct;8(14):2307-13. Review.

PMID:
17927485
4.

Principal components and further possibilities with the PANSS.

von Knorring L, Lindström E.

Acta Psychiatr Scand Suppl. 1995;388:5-10. Review.

PMID:
7541600
5.

Symptom rating scales and outcome in schizophrenia.

Mortimer AM.

Br J Psychiatry Suppl. 2007 Aug;50:s7-14. Review.

PMID:
18019038
6.

Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release.

Pani L, Marchese G.

Expert Opin Drug Deliv. 2009 Mar;6(3):319-31. doi: 10.1517/17425240902780158. Review.

PMID:
19317589
7.

Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia.

Suzuki T, Uchida H, Sakurai H, Ishizuki T, Tsunoda K, Takeuchi H, Mimura M.

Psychiatry Res. 2015 Jun 30;227(2-3):265-9. doi: 10.1016/j.psychres.2015.02.024. Epub 2015 Apr 1. Review.

PMID:
25882098
8.

Paliperidone for treatment of schizophrenia.

Nussbaum AM, Stroup TS.

Schizophr Bull. 2008 May;34(3):419-22. doi: 10.1093/schbul/sbn015. Epub 2008 Mar 28. Review.

9.

Paliperidone extended-release tablets: a new atypical antipsychotic.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2007 May;45(5):15-8. Review.

PMID:
17526326
10.

Paliperidone-ER: first atypical antipsychotic with oral extended release formulation.

Lautenschlager M, Heinz A.

Expert Rev Neurother. 2008 Feb;8(2):193-200. doi: 10.1586/14737175.8.2.193. Review.

PMID:
18271706
11.

The pharmacology and safety of paliperidone extended-release in the treatment of schizophrenia.

Spina E, Cavallaro R.

Expert Opin Drug Saf. 2007 Nov;6(6):651-62. Review.

PMID:
17967154
12.

The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia.

Juckel G, Morosini PL.

Curr Opin Psychiatry. 2008 Nov;21(6):630-9. doi: 10.1097/YCO.0b013e328314e144. Review.

PMID:
18852573
13.

Criterion B (social dysfunction) in persons with schizophrenia: the puzzle.

Stanghellini G, Ballerini M.

Curr Opin Psychiatry. 2007 Nov;20(6):582-7. Review.

PMID:
17921759
14.

Reliability and validity of current physical examination techniques of the foot and ankle.

Wrobel JS, Armstrong DG.

J Am Podiatr Med Assoc. 2008 May-Jun;98(3):197-206. Review.

PMID:
18487593

Supplemental Content

Support Center